家禽用ワクチン市場：疾患タイプ、技術、剤形別-世界予測2025～2030年

家禽用ワクチン市場の2023年の市場規模は20億7,000万米ドルで、2024年には22億3,000万米ドルに達すると予測され、CAGR 7.86%で成長し、2030年には35億1,000万米ドルに達すると予測されています。

家禽用ワクチン市場の範囲は、鳥インフルエンザ、ニューカッスル病、伝染性気管支炎などの家禽の感染症予防を目的としたワクチンの開発、生産、流通を包含します。これらのワクチンは、家禽の健康を確保し、食料安全保障を強化し、養鶏産業の経済的安定を支えるために不可欠です。家禽用ワクチンの必要性は、家禽が感染症に罹患しやすく、経済的に大きな損失をもたらし、食糧供給を危うくする可能性があることからも明らかです。これらのワクチンの最終用途は、商業養鶏場、孵化場、動物病院など広範囲に及んでいます。

この市場の主要成長要因には、家禽疾病の発生率の増加、タンパク質源としての家禽の需要の増加、組み換えワクチンやカプセル化法などのワクチン送達技術の進歩が含まれます。最新のビジネス機会は、バイオセキュリティ対策が重視されるようになったことや、有機農業の動向の高まりから生じており、これには強固な疾病予防システムが必要です。推奨事項の中には、企業はより効率的なワクチンの研究開発に投資する必要があるというものがあります。

市場開拓を阻む課題としては、厳しい規制ポリシー、ワクチン開発に伴う高コスト、ワクチン流通のためのコールドチェーン物流などが挙げられます。さらに、現在のワクチン能力を上回る新興疾患も大きな障壁となる可能性があります。

技術革新と研究は、製造期間の短いワクチンの開発と、ヒト用ワクチンで脚光を浴びているmRNA技術のような新規手法の探求に注力すべきです。さらに、ワクチン投与の自動化とデジタル追跡システムは、業務を合理化し、ワクチンの影響評価を改善する可能性があります。

市場力学はダイナミックであり、先進的競争と規制当局のモニタリングが特徴です。ワクチン開発に革新をもたらし、新たな技術やデータ分析を活用する企業は、この不可欠なセグメントでサステイナブル成長を達成する上で有利な立場にあります。

市場力学：急速に進化する家禽用ワクチン市場の主要市場洞察を公開

家禽用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 動物疾病の発生率の増加
  • 世界の動物ワクチン接種に対する意識の高まり
  • 世界の家禽タンパク質の消費量増加
• 市場抑制要因
  • 偽造医薬品の入手可能性
• 市場機会
  • ワクチン製造技術の進歩
  • 食品の安全性を高めるための継続的な狙いと、政府の積極的な取り組み
• 市場課題
  • 厳しい規制承認とコンプライアンスへの懸念
  • 獣医療的検査とサービスの高コスト

ポーターのファイブフォース：家禽用ワクチン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：家禽用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、家禽用ワクチン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：家禽用ワクチン市場における競合情勢の把握

家禽用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：家禽用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、家禽用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：家禽用ワクチン市場における成功への道筋を描く

家禽用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 動物の病気の発生率の増加
    • 動物ワクチン接種に関する意識が世界的に高まる
    • 世界中で鶏肉タンパク質の消費が増加
  • 抑制要因
    • 偽造医薬品の入手可能性
  • 機会
    • ワクチン製造における技術の進歩
    • 食品の安全性向上に向けた継続的な目標と政府の好ましい取り組み
  • 課題
    • 厳格な規制承認とコンプライアンスの懸念
    • 獣医検査とサービスの高コスト
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 家禽用ワクチン市場：疾患タイプ別

• イントロダクション
• 感染性気管支炎
• マレック病
• ニューキャッスル病

第7章 家禽用ワクチン市場：技術別

• イントロダクション
• 不活性化
• 生弱毒化ワクチン
• 組み換え
• トキソイド

第8章 家禽用ワクチン市場：剤形別

• イントロダクション
• 凍結乾燥
• 液体

第9章 南北アメリカの家禽用ワクチン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の家禽用ワクチン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの家禽用ワクチン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Adnimalis Group
• Anicon Labor GmbH
• Bayer AG
• Biovac Ltd.
• Biovet Private Limited
• Boehringer Ingelheim International GmbH
• Eli Lilly and Company
• Life Circle Nutrition AG
• Medicavet
• Merck & Co., Inc.
• Nutriment Health Pty. Ltd.
• Phibro Animal Health Corporation
• Qilu Animal Health Products Co., Ltd.
• Virbac Group
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. POULTRY VACCINE MARKET RESEARCH PROCESS
• FIGURE 2. POULTRY VACCINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POULTRY VACCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POULTRY VACCINE MARKET DYNAMICS
• TABLE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 29. CANADA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. CANADA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 46. CHINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CHINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 49. INDIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. INDIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 101. ITALY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ITALY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 113. POLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. POLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 116. QATAR POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. QATAR POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 146. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

The Poultry Vaccine Market was valued at USD 2.07 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 3.51 billion by 2030.

The scope of the poultry vaccine market encompasses the development, production, and distribution of vaccines aimed at preventing infectious diseases in poultry, such as avian influenza, Newcastle disease, and infectious bronchitis. These vaccines are critical for ensuring poultry health, enhancing food security, and supporting the economic stability of the poultry industry. The necessity for poultry vaccines is underscored by the high susceptibility of poultry to infectious diseases that can lead to significant economic losses and compromise food supplies. The application of these vaccines is widespread, with end-use markets spanning across commercial poultry farms, hatcheries, and veterinary clinics.

Key growth factors for this market include increasing incidences of poultry diseases, growing demand for poultry as a protein source, and advancements in vaccine delivery technologies such as recombinant vaccines and encapsulation methods. The latest opportunities arise from increased emphasis on biosecurity measures and the rising trend of organic farming, which requires robust disease prevention systems. Among the recommendations is the need for companies to invest in R&D for more efficient vaccines, such as those that provide broader protection and longer-lasting immunity.

Challenges hindering market growth include stringent regulatory policies, high costs associated with vaccine development, and cold chain logistics for vaccine distribution. Furthermore, emerging diseases that outpace current vaccine capabilities can also pose significant barriers.

Innovation and research should focus on developing vaccines with shorter production times and exploring novel methods like mRNA technologies, which have gained prominence in human vaccines. Additionally, automation and digital tracking systems for vaccine administration could streamline operations and improve vaccine impact assessment.

The poultry vaccine market is dynamic, characterized by a high level of competition and regulatory oversight. Businesses that innovate in vaccine development and utilize emerging technologies and data analytics are well-positioned to achieve sustainable growth in this essential sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Poultry Vaccine Market

The Poultry Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of animal diseases
  • Surge in awareness on animal vaccination globally
  • Rising consumption of poultry protein worldwide
• Market Restraints
  • Availability of counterfeit medicine
• Market Opportunities
  • Technological advancements for vaccine manufacturing
  • Ongoing aim to increase food safety coupled with favorable government initiatives
• Market Challenges
  • Strict regulatory approval and compliance concerns
  • High cost of veterinary testing and services

Porter's Five Forces: A Strategic Tool for Navigating the Poultry Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Poultry Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Poultry Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Poultry Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Poultry Vaccine Market

A detailed market share analysis in the Poultry Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Poultry Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Poultry Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Poultry Vaccine Market

A strategic analysis of the Poultry Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Poultry Vaccine Market, highlighting leading vendors and their innovative profiles. These include Adnimalis Group, Anicon Labor GmbH, Bayer AG, Biovac Ltd., Biovet Private Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Life Circle Nutrition AG, Medicavet, Merck & Co., Inc., Nutriment Health Pty. Ltd., Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Virbac Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Poultry Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease Type, market is studied across Infectious Bronchitis, Marek's Disease, and New Castle Disease.
• Based on Technology, market is studied across Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.
• Based on Dosage Form, market is studied across Freeze Dried Vaccines and Liquid.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of animal diseases
    • 5.1.1.2. Surge in awareness on animal vaccination globally
    • 5.1.1.3. Rising consumption of poultry protein worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of counterfeit medicine
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements for vaccine manufacturing
    • 5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory approval and compliance concerns
    • 5.1.4.2. High cost of veterinary testing and services
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Poultry Vaccine Market, by Disease Type

• 6.1. Introduction
• 6.2. Infectious Bronchitis
• 6.3. Marek's Disease
• 6.4. New Castle Disease

7. Poultry Vaccine Market, by Technology

• 7.1. Introduction
• 7.2. Inactivated
• 7.3. Live Attenuated Vaccines
• 7.4. Recombinant
• 7.5. Toxoid

8. Poultry Vaccine Market, by Dosage Form

• 8.1. Introduction
• 8.2. Freeze Dried Vaccines
• 8.3. Liquid

9. Americas Poultry Vaccine Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Poultry Vaccine Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Poultry Vaccine Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adnimalis Group
• 2. Anicon Labor GmbH
• 3. Bayer AG
• 4. Biovac Ltd.
• 5. Biovet Private Limited
• 6. Boehringer Ingelheim International GmbH
• 7. Eli Lilly and Company
• 8. Life Circle Nutrition AG
• 9. Medicavet
• 10. Merck & Co., Inc.
• 11. Nutriment Health Pty. Ltd.
• 12. Phibro Animal Health Corporation
• 13. Qilu Animal Health Products Co., Ltd.
• 14. Virbac Group
• 15. Zoetis Inc.